Pharmacotherapy of HTN Flashcards
(42 cards)
Epidemiology of HTN
1/3 adults in US have HTN
About 70% of people with MI, CVA, or heart failure have BP >140/90
Normal BP
<120/80
Pre-HTN
120-139/80-89
Stage 1 HTN
140-159/90-99
Stage 2 HTN
>160/100
CVD risk doubles with what increase in BP?
20/10
Evaluation of elevated BP
- Asses lifestyle and identify other CV RFs or concomitant disorders
- Reveal identifiable causes of high BP (primary vs secondary HTN)
- Asses the presence or absence of target organ damage
JNC 7 Major Cardiovascular Disease RFs
HTN
Tobacco Use
Obesity
Physical inactivity
DM
Dyslipidemia
Microalbuminuria
Age (55/65)
FHx of premature CVD (MI/sudden death)– 55/65
Definable causes of HTN
(secondary HTN)
Sleep apnea
Chronic kidney disease
Primary aldosteronism
Renovascular disease
Chronic steroid therapy/Cushings syndrome
Pheochromocytoma
Coarctation of the aorta
Thyroid or parathyroid disease
Medications that can cause HTN
NSAIDs
Corticosteroids
Oral contraceptives
Cocaine, amphetamines
Sympathomimetics
Erythropoieten
Licorice
Target Organ Damage
Heart: LV hypertrophy, angina or prior MI, prior coronary revascularization, heart failure
Brain: stroke/TIA
Nephropathy
Peripheral artery disease
Retinopathy
Goal of HTN therapy
Reduce CVD and renal morbidity and mortality
Achieve SBP goal
Blood pressure goals for uncomplicated HTN
<140/90
Blood pressure goals if also have DM, renal disease, CAD, CAD equivalents, Framingham score >10%, or left ventricular heart failure
<130/80
The Big 5: Lifestyle Modifications to Manage HTN
- Weight reduction
- DASH diet
- Decrease Sodium intake
- Physical activity
- Moderation of alcohol consumption
Pharm treatment decreases the risk of what?
clearly decreases the incidence of cardiovascular morbidity and mortality
Dec BP by 5-6 leads to 42% dec in stroke and 14% in CHD
Potential additive favorable and unfavorable effects of thiazide diuretics
Useful in slowing osteoporosis
Should be used cautiously with history of gout or hyponatremia
Potential additive favorable and unfavorable effects of BBs
Useful in treating atrial tachyarrhythmias/fib, migraine, essential tremor, perioperative HTN
Avoid in pts with asthma, reactive airways disease, or second/third degree heart block
Potential additive favorable and unfavorable effects of CCBs
Useful in Raynuad’s syndrome and certain arrhythmias
Potential additive unfavorable effects of ACEI
Do not use in women who are pregnant or may become pregnant
Do not use if hx of angioedema
Preferred Combos of synergistic antihypertensives
ACEI + thiazide
ACEI + DHP CCB
ARB + thiazide
ARB + DHP CCB
NOT preferred combos of antihypertensives
ACEI + ARB
BB + ACEI or ARB
BB + NDHP CCB
BB + Central acting
Follow up in pts being treated for HTN
Patients should return of f/u and adjustment of meds until goal is reached:
- Check BP 2-4 weeks after start or change in dose, assess response after 4-6wks
- More frequent visits for stage 2 or if comorbid conditions
After BP at goal, f/u at 3-6 month intervals
Serum potassium and creatinine montitored 1-2times/year
May come in more frequently if other comorbid conditions
Monitoring of pts being treated for HTN
- Diuretics
- Aldosterone antagonists
- ACEI
- ARBs
- CCB
- BB
Diuretics
- K, Mg, UA, Cr, Na, BG
Aldosterone antagonists, ACEI, ARBs
- Cr, K
CCB, BB
- HR